1-2 of 2
for the Nordic Lymphoma Group
Close
Sort by
Journal Articles

The Mantle Cell Lymphoma International Prognostic Index (MIPI) is superior to the International Prognostic Index (IPI) in predicting survival following intensive first-line immunochemotherapy and autologous stem cell transplantation (ASCT)

Brief Report
Christian H. Geisler, Arne Kolstad, Anna Laurell, Riikka Räty, Mats Jerkeman, Mikael Eriksson, Marie Nordström, Eva Kimby, Anne Marie Boesen, Herman Nilsson-Ehle, Outi Kuittinen, Grete F. Lauritzsen, Elisabeth Ralfkiær, Mats Ehinger, Christer Sundström, Jan Delabie, Marja-Liisa Karjalainen-Lindsberg, Peter Brown, Erkki Elonen, for the Nordic Lymphoma Group
Journal: Blood
Blood (2010) 115 (8): 1530–1533.
https://doi.org/10.1182/blood-2009-08-236570
Published: 2010
Includes: Supplemental data
Journal Articles

Long-term progression-free survival of mantle cell lymphoma after intensive front-line immunochemotherapy with in vivo–purged stem cell rescue: a nonrandomized phase 2 multicenter study by the Nordic Lymphoma Group

Clinical Trials & Observations
Christian H. Geisler, Arne Kolstad, Anna Laurell, Niels S. Andersen, Lone B. Pedersen, Mats Jerkeman, Mikael Eriksson, Marie Nordström, Eva Kimby, Anne Marie Boesen, Outi Kuittinen, Grete F. Lauritzsen, Herman Nilsson-Ehle, Elisabeth Ralfkiær, Måns Åkerman, Mats Ehinger, Christer Sundström, Ruth Langholm, Jan Delabie, Marja-Liisa Karjalainen-Lindsberg, Peter Brown, Erkki Elonen, for the Nordic Lymphoma Group
Journal: Blood
Blood (2008) 112 (7): 2687–2693.
https://doi.org/10.1182/blood-2008-03-147025
Published: 2008